These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [miR-145 inhibits lung adenocarcinoma stem cells proliferation by targeting OCT4 gene].
    Author: Zhang S, Wu Y, Feng D, Zhang Z, Jiang F, Yin R, Xu L.
    Journal: Zhongguo Fei Ai Za Zhi; 2011 Apr; 14(4):317-22. PubMed ID: 21496429.
    Abstract:
    BACKGROUND AND OBJECTIVE: MiR-145 functions as a protective miRNA identified in tumor tissues of lung adenocarcinoma patients. The aim of this study is to investigate the relationship between miR-145 and proliferation of lung cancer stem cells and involved molecular mechanisms in human lung adenocarcinoma A549 cell line. METHODS: MicroRNA microarray technology was conducted to compare miRNA signature between tumor and adjacent normal tissue of lung adenocarcinoma. The potential target gene of miR-145 was predicted by online bioinformatic softwares. Pre-miR-145 mimics and anti-miR-145 inhibitor were transfected into A549 cell line by lipofectamine 2000. miR-145 expression in each group was detected by real time PCR. The OCT4 protein level was analyzed by Western blot. The predicted miR-145 binding site in OCT4 3'-untranslated region (UTR) was validated by dual-luciferase reporter gene assay. CCK-8 assay was employed to observe the proliferation activity of A549 cells. The ratio of CD133 positive cells in each group was analyzed by flow cytometry. RESULTS: miR-145 expression was significantly down-regulated in lung adenocarcinoma compared with ajacent normal tissue. OCT4 is a potential target gene of miR-145 predicted by miRanda. Compared with control group, miR-145 was significantly up-regulated and down-regulated in the pre-miR-145 mimics and anti-miR-145 inhibitor groups respectively. Overexpression of miR-145 inhibited the proliferation of A549 cells. Both the OCT4 protein level and CD133 positive ratio were remarkably decreased in the pre-miR-145 mimics group, whereas significantly increased in the anti-miR-145 inhibitor group. Dual-luciferase reporter gene assay validated the predicted miR-145 binding site of OCT4 3'UTR. CONCLUSIONS: MiR-145 can inhibit the proliferation of lung cancer stem cells in A549 cell line via down-regulating OCT4 expression. MiR-145 is a potential protective miRNA of lung cancer. 背景与目的: miR-145是通过miRNA芯片及qPCR验证筛选出的一种潜在肺癌“保护性”miRNA。本研究旨在探讨miR-145与肺癌干细胞之间的关系及分子机制。 方法: miRNA芯片对肺腺癌患者瘤旁和正常组织进行表达谱分析；生物信息学软件预测miR-145潜在的靶基因；脂质体2000介导转染miR-145模拟物和阻遏物进入A549细胞株；实时定量PCR检测miR-145表达水平；Western blot检测OCT4蛋白水平；双荧光素酶报告基因验证miR-145是否作用于OCT4 mRNA的3’UTR区预测靶位；细胞增殖实验检测miR-145对于A549细胞生长的作用；流式细胞术检测干细胞表型CD133+的表达。 结果: 在肺腺癌组织中miR-145表达明显低于瘤旁正常组织；miRanda软件预测OCT4是miR-145潜在靶基因；与对照组相比，miR-145模拟物组和阻遏物组miR-145表达分别明显上调和下调；miR-145对A549细胞的生长有双向调节作用，过表达miR-145抑制细胞生长；过表达miR-145可明显降低OCT4蛋白水平及干细胞表型CD133百分比，而抑制miR-145表达则明显增加OCT4蛋白水平及CD133百分比。双荧光素酶报告基因检测证明miR-145可作用于OCT4 mRNA的3’UTR区预测靶位。 结论: miR-145可通过下调OCT4基因表达抑制A549肺腺癌细胞株中干细胞的增殖，是一种潜在的肺癌“保护性”miRNA。
    [Abstract] [Full Text] [Related] [New Search]